Location History:
- Sommerville, MA (US) (2020)
- Somerville, MA (US) (2022)
Company Filing History:
Years Active: 2020-2025
Title: **Or A Shemesh: Innovator in Optogenetics and Biological Imaging**
Introduction
Or A Shemesh is a prominent inventor based in Somerville, Massachusetts, with significant contributions to the fields of optogenetics and biological imaging. He holds two patents that reflect his innovative approaches to understanding and manipulating cellular activities.
Latest Patents
Shemesh's latest patents include groundbreaking inventions such as "Somatic opsins for single cell resolution optogenetics" and "Stochastic arrangement of reagents in clusters—STARC". The first patent focuses on polypeptide molecules and their encoding nucleic acid molecules, aimed at targeting opsins to the soma of cells. This invention has potential applications in modulating electrical activity in cells, contributing to advancements in treatments for various diseases. The second patent addresses methods for imaging biological systems and physiological activities within cells, providing new avenues for studying cell behavior and functions.
Career Highlights
Or A Shemesh is affiliated with the Massachusetts Institute of Technology, where he works alongside some of the leading minds in the field. His innovative research and patents reflect his dedication to advancing scientific knowledge and practical applications in biotechnology.
Collaborations
Throughout his career, Shemesh has collaborated with esteemed colleagues, including Edward Stuart Boyden and Changyang Linghu. These collaborations have further enriched the scope of his research and contributed to impactful innovations in the realm of cellular technology.
Conclusion
Or A Shemesh stands out as an influential inventor whose work is crucial in the evolution of optogenetics and biological imaging techniques. His patented inventions have the potential to significantly impact the medical field, enhancing our understanding of cellular functions and paving the way for novel therapeutic strategies.